All posts by admin

Business Wire India

CRLAB ties up with Hairline International to bring next-gen non-surgical hair replacement to India. This strategic partnership comes at a time when hair loss has become increasingly prominent in the country. Studies indicate that nearly 60% of men and 40% of women experience some form of hair loss during their lifetime. These numbers were earlier associated with the 35-50 age group. Today, younger individuals are also reporting similar concerns.

This shift is changing how people approach hair restoration. Many consumers now prefer solutions that restore confidence without surgery. Non-surgical hair replacement is gaining attention across the country. They promise faster results and require no medical recovery time. Consumer expectations have also shifted. People don’t just want to cover hair loss: they want to look and feel good.

Modern hair treatments now prioritise natural aesthetics, volume, density, and length. The goal is simple. The result should look and feel like natural hair. Advances in materials and scalp-friendly bases are helping achieve this. Improvements in hair sourcing have also played an important role. Together, these developments are reshaping what hair fixing solutions can offer.

Older hairpieces often struggled to look realistic. Visible bases made them easy to detect. Styling options were limited, and hair quality was also inconsistent. Today’s non-surgical hair systems are designed very differently. The focus is on comfort, durability, and natural movement. Premium systems now use combinations of Indian hair, virgin hair, and Remy hair. Each type offers distinct qualities in texture and strength. Remy hair maintains smoothness and reduces tangling by keeping the natural cuticle alignment intact. Virgin hair retains its natural shine and structural strength since it isn’t chemically processed. Such root-level improvements allow modern hair systems to appear more natural.

The Indian hair restoration market attracts various international collaborations. This is driving innovation. Case in point is the partnership between Hairline International Hair and Skin Clinic and CRLAB. CRLAB is a European hair technology company popularised by its research-driven approach to non-surgical hair replacement. European quality standards are now knocking at the Indian market. At the same time, the systems are adapted to suit Indian hair textures and everyday lifestyle conditions.

Bani Anand, Managing Director, Hairline Hair And Skin Clinics, says:

“It’s exciting to spearhead this revolution. CNC is a big promise for those who seek a natural-looking hairpiece that is like their second skin. We are optimistic about this partnership and look forward to leveraging CRLAB’s expertise. Our Indiranagar and Kormangala branches are fully equipped to implement innovations.”

Angelo D’Andrea, CEO, CRLAB, shared his perspective on the collaboration:

“India is a ripe market for non-surgical hair replacement. Consumers here are increasingly aware of global innovations. They are also looking for solutions that deliver natural results. Through our collaboration with Hairline, we hope to bring European craftsmanship, advanced hair system design, and precision hair technologies to India. This will greatly benefit individuals seeking reliable alternatives to surgical hair restoration.”

This partnership reflects a broader industry trend. Global hair technology providers are now working closely with Indian clinics. The goal is to deliver more refined and reliable hair restoration solutions.

Hair restoration solutions come in various shapes and sizes (and textures). Consumers can choose products based on their hair loss pattern, styling needs, and personal preferences. There are options like hair toupees, hair wigs, hair closures, fringes, bands, bangs, and ponytail extensions. Each solution allows volume, density, and length customisation, and even comes with your name on the piece. Every product is dermatologically tested and compatible with Indian skin. The result is a more personalised approach to hair restoration.

Maintenance has also improved over the years. Specialised hair spa treatments for hair systems help maintain texture and hydration. They also improve the longevity of hairpieces. Regular care ensures the systems retain their natural appearance over time.

Hair restoration technologies are evolving rapidly in every part of the world. For example, researchers are exploring innovations such as 3D bio printing of hair follicles. This could potentially disrupt regenerative science with CNC hair that comes with a second skin system that perfectly matches scalp size and undulations for a snug fit. As research and development are underway, non-surgical hair replacement systems offer temporary respite to those experiencing hair thinning or hair loss. International collaborations are accelerating this progress. Partnerships between innovators like CRLAB and established Indian clinics such as Hairline are bringing advanced solutions closer to consumers.

Indians can now explore non-surgical hair replacement options with increasing confidence.

Website: https://www.hairline.co.in/cnc-hair-patch-in-bangalore/.

Business Wire India

The Office of His Highness Sheikh Hamdan Bin Ahmed Al Maktoum Holdings, in collaboration with Gatbits IT Infrastructure, has officially announced the launch of the GTBS Digital Ecosystem, marking a significant step forward in the global Web3 space. The announcement follows the successful launch of the native GTBS Coin on December 25, with the ecosystem’s mainnet scheduled to go live in April 2026.

 

GTBS represents a full-stack Web3 ecosystem integrating blockchain, artificial intelligence, decentralized finance (DeFi), entertainment, gaming, media, and cloud infrastructure into a unified platform. Built on the philosophy of “All Commitment On Time,” the ecosystem focuses on delivering reliability, scalability, and real-world utility.

 

 

Designed as a comprehensive digital infrastructure, GTBS goes beyond standalone crypto platforms by offering an integrated environment for users, developers, creators, and enterprises. Its proprietary Layer-1 blockchain powers seamless interaction across services while ensuring high speed, low transaction costs, and scalability.

 

 

The ecosystem is structured around key components, including the GTBS Blockchain, a high-performance Layer-1 network; GTBS Wallet for secure asset management; GatBits Exchange, an AI-driven trading platform; GTBS Media / Flicksy, a decentralized content streaming service; GTBS Games & Metaverse (Gugly), enabling Play-to-Earn and immersive experiences; and GTBS Cloud, offering decentralized storage and enterprise-grade solutions.

 

 

With its integrated approach and phased rollout, GTBS is positioned to drive real-world adoption and support a wide range of digital use cases from day one. The upcoming mainnet launch is expected to unlock the full potential of the ecosystem, enabling direct participation in its decentralized infrastructure.

 

 

Media & Community Information

 

 

Website: https://gtbs.live

 

 

Download App: https://play.google.com/store/apps/details?id=com.gatbits.exchange

 

 

Telegram: https://t.me/GTBSchain

 

 

Instagram: https://www.instagram.com/gatbits_gtbschain

 

 

X (Twitter): https://x.com/Gtbschain

 

 

For media inquiries and partnerships, please connect via the official platforms listed above.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260325551161/en/

 

Business Wire India

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO).

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/

 

 

 

Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI.

 

“We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around the world.”

 

 

Enbom brings deep experience in cybersecurity and identity security, having built and led global go-to-market organizations across sales and marketing. With a foundation in engineering and a track record of leading cross-functional business initiatives, she brings a 360-degree perspective on the business that enables organizations to scale securely while staying grounded in business outcomes.

 

 

At Yubico, Enbom will lead the company’s global marketing and business development organizations, aligning strategy, leverage sales and execution to accelerate demand and grow revenue. As a core part of its go-to-market strategy, she’ll focus on strengthening executive engagement and advancing Yubico’s leadership in hardware-backed authentication and passwordless adoption: to protect our digital world from AI-Powered Adversary-in-the-Middle Phishing.

 

 

“Yubico built the foundation of modern authentication and continues to play a pivotal role in shaping the future, along with setting the standard for phishing-resistant security and delivering the original passkey,” said Enbom. “What stands out is not only the company’s innovation, but its deep commitment to customers to build open, trusted solutions that scale globally. I’m excited to join this mission-driven team and help more organizations and users to protect digital identities in an increasingly complex threat landscape.

 

 

About Yubico

 

 

Yubico (NASDAQ STOCKHOLM: YUBICO) is a modern cybersecurity company on a mission to make the digital world safer for everyone. As the inventor of the YubiKey, we set the gold standard for modern phishing-resistant, hardware-backed authentication, stopping account takeovers and making secure login simple.

 

 

Since 2007, we’ve helped shape global authentication standards, co-created FIDO2, WebAuthn, and FIDO U2F, and introduced the original passkey. Today, our passkey technology secures people and organizations in over 160 countries—transforming how digital identity is protected from onboarding to account recovery.

 

 

Trusted by the world’s most security-conscious brands, governments, and institutions, YubiKeys work out of the box with hundreds of apps and services, delivering fast, passwordless access without friction or compromise.

 

 

We believe strong security should never be out of reach. Through our philanthropic initiative, Secure it Forward, we donate YubiKeys to nonprofits supporting at-risk communities.

 

 

Headquartered in Stockholm, Sweden; Santa Clara, California; and Singapore, Yubico is proud to be recognized as one of TIME’s 100 Most Influential Companies and Fast Company’s Most Innovative Companies. Learn more at www.yubico.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330278027/en/

 

Business Wire India

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/

 

 

 

WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate the safety of the Edison® Histotripsy System for the treatment of symptomatic benign prostatic hyperplasia (BPH). The trial is expected to enroll and treat up to 20 patients. Following treatment, participants will undergo imaging within 72 hours of the procedure to assess the immediate treatment effect. Patients will then be followed longitudinally to further evaluate safety and procedural outcomes.

 

“BPH affects millions of men worldwide and most of the existing treatment options require invasive procedures or lengthy recovery times,” said Mike Blue, Chairman and CEO, HistoSonics. “We believe histotripsy’s ability to mechanically destroy targeted tissue, completely non-invasively, has the potential to transform how BPH is treated. In addition, this milestone represents significant progress in our pursuit to expand the unique benefits of histotripsy over a significant number of serious clinical conditions throughout the body.”

 

 

“We are excited and extremely proud that Prince of Wales Hospital is the first center in the world to offer this novel treatment approach in a clinical trial and potentially benefit patients with BPH in the future,” said Dr. Peter Chiu, study investigator and Associate Professor of The Chinese University of Hong Kong. “If shown to be safe and effective, the non-invasive nature of histotripsy has the potential to change how BPH is treated for many patients suffering from lower urinary tract symptoms around the world.”

 

 

Benign prostatic hyperplasia is one of the most common urological conditions affecting aging men. Approximately 50 percent of men over the age of 50 and up to 80 percent of men over the age of 80 experience symptoms associated with BPH. Globally, more than 110 million men are affected by the condition, and its prevalence is expected to continue increasing as populations age.

 

 

The Edison Histotripsy System is currently cleared in the United States for the destruction of liver tumors. The use of the Edison System for the treatment of benign prostatic hyperplasia is currently limited to investigational use.

 

 

About HistoSonics

 

 

HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquefy unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, MI and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: www.histosonics.com. For patient-related information please visit: www.myhistotripsy.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330349844/en/

 

Business Wire India

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano^® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs.

 

Under the terms of the agreement, Taisho will leverage RenNano^® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed.

 

 

“We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano^® is a robust and powerful fully human VHH discovery platform that provides an ideal antibody foundation for the development of a broad range of next-generation innovative therapeutics. Through this collaboration, RenNano^® will support Taisho’s internal R&D efforts and help establish a more efficient, fully human VHH discovery workflow.”

 

 

This collaboration further expands Biocytogen’s growing portfolio of global partnerships. Leveraging its robust in vivo immune response, the RenNano^® platform enables the efficient generation of fully human heavy-chain-only antibodies with high diversity, specificity, affinity, and favorable developability. The platform comprehensively supports next-generation VHH-based antibody modalities, including bispecific antibodies, antibody-drug conjugates (ADCs), and in vivo CAR-T therapies.

 

 

About Biocytogen

 

 

Biocytogen (SSE: 688796; HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen has established a dual-engine platform combining a fully human antibody library with an extensive target-humanized mouse model portfolio, enabling a systematic approach to accelerating global drug discovery and development.

 

 

Biocytogen has independently developed its proprietary RenMice^® (RenMab^®/ RenLite^®/ RenNano^®/RenTCR™/ RenTCR mimic™) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, hu-VHH discovery, and TCR mimic antibody discovery, and has established a sub-brand, RenSuper™ Biologics, to explore global partnerships for an off-the-shelf library of >1,000,000 fully human antibody sequences against over 1000 targets for worldwide collaboration. As of December 31, 2025, more than 350 agreements for therapeutic antibodies and clinical assets—spanning co-development, out-licensing, and transfers—have been established globally, including landmark partnerships with leading multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen, Jiangsu, Shanghai), the USA (Boston, San Francisco, San Diego), and Germany (Heidelberg). For more information, please visit https://biocytogen.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330812518/en/

 

Business Wire India

The latest research from Omdia shows that US PC shipments (excluding tablets) grew 3% year-on-year in Q4 2025 to 18.2 million units, reversing two consecutive quarters of annual decline. The return to growth was driven by a combination of the peak of Windows 11 commercial refreshes, holiday-season demand, and vendor efforts to secure inventory ahead of anticipated memory and storage supply constraints in 2026. Full-year 2025 shipments reached 71.5 million units, up 3% from 2024, but 2026 shipments are now forecast to decline 13% year-on-year due to highly constrained supply of memory and storage products.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330580326/en/

 

 

 

“Q4 marked a meaningful inflection point for the US PC market,” said Kieren Jessop, Research Manager at Omdia. “After two quarters of year-on-year decline, the market returned to growth driven by solid performances across both the consumer and commercial segments. Consumer shipments rose 6% to 8.2 million units – the fourth consecutive quarter of annual growth – underpinned by holiday spending and a product mix shift to more affordable price ranges. The commercial segment grew 4% as enterprises continued their Windows 11 migration, particularly in the final stretch before the Windows 10 end-of-support deadline in October.”

 

Jessop continued, “The education segment remains a weak spot, declining 11% in Q4, although this was a notable improvement from the 29% drop in Q3 and the 16% decline in Q2. Reduced federal and state funding continues to weigh on school procurement, but we believe much of the inventory overhang that characterized the middle of the year has now been cleared. Government shipments edged up 1%, stabilizing after the sharp pullback earlier in 2025.”

 

 

“Looking ahead, the outlook for 2026 is significantly more cautious. Memory and storage costs have risen 40–70% since the start of 2025, and Omdia expects at least a further 60% increase in mainstream PC memory and storage costs in Q1 2026. These supply constraints are expected to have the greatest impact on the sub-$500 segment, which includes most education and entry-level consumer devices. As thinner margins and lower allocation priority constrain the low-end market, smaller vendors are especially at risk of being squeezed out of the market,” Jessop added.

 

 

Omdia forecasts US PC shipments to decline 13% in 2026 to approximately 61.9 million units before recovering modestly in 2027.

 

 

US desktop and notebook forecast   Omdia PC Forecast: 2025 to 2027
Segment	2025 shipments	2026 shipments	2027 shipments	2025 annual growth	2026 annual growth	2027 annual growth
Consumer	27,695	24,269	25,566	5.2%	-12.4%	5.3%
Commercial	31,221	28,333	29,152	6.0%	-9.2%	2.9%
Government	3,840	3,629	3,738	0.1%	-5.5%	3.0%
Education	8,760	5,645	7,735	-8.7%	-35.6%	37.0%
Total	71,516	61,877	66,191	3.3%	-13.5%	7.0%
Note: Unit shipment in thousands. Totals may not add up due to rounding.   Source: Omdia PC Horizon Service (sell-in shipments), March 2026

 

 

“Dell, which surged 22% year-on-year to claim the number two position in Q4 with a 25% market share had its strongest quarterly performance in the US in over two years. Its growth was concentrated in the commercial segment, where it benefited from large enterprise refresh deals and strong momentum in its premium lines. HP retained the top spot with 25% share despite more modest 1% growth, while Lenovo and Apple each recorded market share in the mid-teens.

 

For full-year 2025, however, the biggest story at the vendor level was Apple, which has been making market share gains in US businesses, reaching an 11% share in full year 2025: up 2.4 percentage points from 2024. This growth was driven by the MacBook Air, especially after doubling the M4 Air’s memory to 16GB while reducing the price by $100, bringing it back to the M1’s $999 price point. The $599 Neo extends that value trajectory and is expected to significantly disrupt the entry-level segment,” Jessop concluded.

 

 

US desktop and notebook shipments (market share and annual growth)   Omdia PC Market Pulse: 4Q25
Vendor	4Q25 shipments	4Q25 market share	4Q24 shipments	4Q24 market share	Annual growth
HP	4,560	25.0%	4,495	25.5%	1.4%
Dell	4,485	24.6%	3,679	20.8%	21.9%
Lenovo	2,961	16.3%	2,938	16.6%	0.8%
Apple	2,864	15.7%	3,024	17.1%	-5.3%
Acer	1,013	5.6%	991	5.6%	2.2%
Others	2,335	12.8%	2,526	14.3%	-7.6%
Total	18,217	100.0%	17,653	100.0%	3.2%
Note: Unit shipments in thousands. Percentages may not add up to 100% due to rounding.   Source: Omdia PC Horizon Service (sell-in shipments), March 2026

 

US desktop and notebook shipments (market share and annual growth)   Omdia PC Market Pulse: 2025
Vendor	2025 shipments	2025 market share	2024 shipments	2024 market share	Annual growth
HP	17,772	24.9%	17,479	25.3%	1.7%
Dell	16,745	23.4%	15,805	22.8%	6.0%
Lenovo	12,691	17.7%	11,872	17.2%	6.9%
Apple	11,424	16.0%	10,273	14.8%	11.2%
Acer	3,857	5.4%	4,261	6.2%	-9.5%
Others	9,027	12.6%	9,520	13.8%	-5.2%
Total	71,516	100.0%	69,210	100.0%	3.3%
Note: Unit shipments in thousands. Percentages may not add up to 100% due to rounding.   Source: Omdia PC Horizon Service (sell-in shipments), March 2026

 

ABOUT OMDIA

 

Omdia, part of TechTarget, Inc. d/b/a Informa TechTarget (Nasdaq: TTGT), is a technology research and advisory group. Our deep knowledge of tech markets grounded in real conversations with industry leaders and hundreds of thousands of data points, make our market intelligence our clients’ strategic advantage. From R&D to ROI, we identify the greatest opportunities and move the industry forward.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330580326/en/

 

Business Wire India

Mirae Asset Sharekhan announced the launch of the Mirae Asset India Research Centre, a unified digital research platform designed to strengthen investor decision-making with clear, credible and process‑driven market insights. The Research Centre was launched in Q1 of CY2026.

 

As participation in India’s capital markets widen, the real challenge for investors isn’t finding information- it’s cutting through the clutter. With so much fragmented data across equities, derivatives, mutual funds, commodities and other segments, it can be tough to know what actually matters for investors’ portfolio. The Mirae Asset India Research Centre was built to solve this by offering access to in-depth reports across 220+ stocks spanning over 30+ market sectors. They have brought together seasoned expertise and professional insights, translating complex market data into clear, actionable research that stays relevant across every market cycle.

 

The platform will be a single digital hub that will consolidate Mirae Asset Sharekhan’s research capabilities across equities, derivatives, commodities, mutual funds, ETFs, macroeconomics and thematic strategies into a single, authoritative digital hub. Their aim is to help investors move away from speculation and market “noise” towards informed, research-led investment decisions.

 

Speaking at this launch, Moon Kyung Kang, CEO, Mirae Asset Sharekhan, said, “With the launch of the Mirae Asset India Research Centre Portal, we are focused on bringing structure and clarity to investor decision-making. Our aim is to make expert lead, experience backed research accessible in a simple, actionable format, enabling investors to navigate markets with greater confidence and a long-term perspective.”

Mirae Asset India Research Centre – A Game Changer

• Actionable investment views: Clear Buy / Hold / Sell recommendations supported by valuation frameworks, key risks and scenario analysis.
• Mutual fund insights: Top Picks shortlisted using their Q-Square methodology along with fund performance breakdown to support investment decisions.
• Single-window access: One stop for research calls, reports and thematic insights.
• Quick, visual research: Quick research reads, simplified charts and intuitive green/red indicators for at-a-glance understanding.
• Videos: Fast, accurate research delivered through bite-sized video formats.
• Free Trial: A 15-day free trial is available for non-customers; whereas Mirae Asset Sharekhan customers can access all research calls and detailed reports without any additional cost.

 

What sets their Research Centre apart is a process-driven and transparent approach. Research will be curated separately for retail investors, and institutional clients, ensuring relevance while maintaining analytical depth. In the days ahead, the Mirae Asset India Research Centre will continue to evolve into a broader research ecosystem.

 

Visit the Mirae Asset India Research Centre at: 
https://research.sharekhan.com/?utm_source=press-release

Business Wire India

 

• The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport.
• Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping.
• Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027.

 

The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/

 

 

 

Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that elevates high-performance riders and horses to their rightful place on the world stage. Built on merit, integrity, and excellence, the PJL brings together the world’s best athletes to compete for the biggest prize pot in the discipline’s history, helping to create a more resilient, long-term financial model for the sport.

 

Represented by sixteen teams, the PJL will introduce an industry-first rider selection process from a pool of 250 of the world’s leading riders.

 

 

World-class, immersive events will unfold across fourteen iconic international venues, spanning Europe, North America, and the Middle East inviting fans closer than ever to the grit, beauty, and power of high-stakes jumping.

 

 

The inaugural season will run from March to October 2027.

 

 

Designed to open the sport to new audiences whilst respecting its heritage, the PJL combines extraordinary athletic performance with premium entertainment, strengthened by the league’s partnership with Emmy award-winning production company Box to Box Films, and supported by a free-to-view broadcasting model. Cutting-edge technology, radical transparency, and innovative team formats enhance the drama, intensity, and rivalry that defines elite sport – unlocking the full potential of jumping, demanded by today’s global sports and entertainment marketplace, without compromising its core values.

 

 

With exceptional welfare standards, a pioneering development pathway, and financial sustainability at its core, the PJL is professionalising jumping.

 

 

This is elite sport.

 

 

This is extraordinary skill.

 

 

This is our sport as you’ve always loved it.

 

 

This is our sport as you’ve never seen it.

 

 

This is the PJL – the future of jumping.

 

 

Frank McCourt, Founder and Chairman of the PJL: “For far too long, many of the world’s best riders have been forced to choose between pursuing their talent and passion and building a sustainable career. The PJL is changing that by creating a clear and viable path for athletes to earn a great living by competing at the highest level, without compromising the traditions and values that define jumping. By aligning opportunity with performance and commitment, we are reshaping the future of the sport and empowering its most talented athletes to devote themselves fully to excellence.”

 

 

Neil Moffitt, Chief Executive Officer: “Today marks a major milestone for equestrian sport. The PJL has assembled an exceptional operations team to deliver on our mission to bring a new level of energy, excitement, and engagement to the sport.”

 

 

Lisa Lazarus, Chief Equestrian Advisor: “There is no greatness in horse sport without the welfare and safety of the horse. The PJL’s competition design, scheduling, travel approach, and veterinary oversight will reflect uncompromising standards of care, rest, and responsible decision-making every step of the way.”

 

 

Laura Kraut, Olympic gold medal-winning rider:“An Olympic gold medal is the greatest thing you can achieve in the sport. Yet for jumping athletes like me, the commercial opportunities often don’t follow. The gap between what athletes achieve and what they’re able to build tells you everything about the sport’s limited infrastructure to convert elite achievement into recognition and reward. I welcome the PJL’s values to reform this model in a way that drives revenue opportunities for all involved.”

 

 

Scott Brash, Olympic gold medal winner & current World Number 1 rider:“With horses—and in our sport especially—learning never stops. One of my biggest goals is to help move the sport forward, creating a better environment for athletes, horses, everyone involved, and those who follow along. I believe the PJL gives us a meaningful platform to have these important conversations. Competing at the highest level comes with enormous costs, and for most riders, securing financial support while dedicating the necessary time to the sport is a constant balancing act.

 

 

What makes the PJL so impactful is that it rewards riders in a way that allows us to truly prioritize both our own well-being and that of our horses—making full-time training and proper rest possible. That’s something genuinely groundbreaking.”

 

 

About the Premier Jumping League (PJL)

 

 

The PJL is a new global showjumping competition redefining the sport through elite team competition, record-breaking prize money, and a sustainable professional model for riders. Backed by McCourt Global and shaped by leaders from equestrian sport, international competition, and entertainment, the PJL brings together the world’s top riders and horses to compete across fourteen iconic venues in Europe, North America, and the Middle East. With sixteen teams, an innovative rider selection process and a guaranteed $300 million prize pot, the PJL combines world-class athletic performance with premium entertainment, opening the sport to new global audiences while honouring its heritage.

 

 

About McCourt Global

 

 

McCourt Global is a diversified enterprise building for tomorrow across real estate and infrastructure, sports, technology, and media. With a global portfolio, the company combines operational expertise with strategic capital to develop impactful projects that create long-term economic and social value. Founded by Executive Chairman Frank McCourt, a civic entrepreneur and fifth-generation builder, and led by an international executive team, McCourt Global builds on a 133-year legacy of developing infrastructure and delivering strong financial results alongside a commitment to social impact—an approach that began with the McCourt family’s original company in Boston in 1893.

 

 

McCourt Global’s portfolio includes McCourt Partners, the real estate and infrastructure firm; Olympique de Marseille, the iconic Ligue 1 football club; the Premier Jumping League, a global showjumping competition redefining the sport; and Project Liberty, an initiative to build a better internet where individuals have greater control over their data in the era of AI. Headquartered in New York, McCourt Global operates across North America, Europe, and beyond. For more information, visit McCourt Global’s website or follow the company on LinkedIn.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330990938/en/

 

Business Wire India

Mylan Laboratories Limited (a Viatris Company) has been Certified™ by Great Place To Work® in India for the fifth year in a row. The award is based entirely on what employees say about their experience working at Viatris in India. This year, 86% of employees said it’s a Great Place To Work.

 

Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. This recognition is the result of an independent evaluation, which uses a rigorous two-step process that includes an anonymous survey to employees and a specific evaluation of the company’s corporate culture, assessing the practices, policies, and HR and leadership culture of the organization. 

 

“Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience,” says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that Certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. “By successfully earning this recognition, it is evident that Viatris stands out as one of the top companies to work for, providing a great workplace environment for its employees.”

 

“This milestone reflects our people-first philosophy and our sustained efforts to create an environment where all colleagues feel valued, empowered, and supported in their growth. At Viatris, we remain committed to fostering wellbeing, inclusivity and continuous development so that our people can bring their best to work every day,” says Anupam Bhatt, Head of Human Relations, Viatris in India.

Business Wire India

Global IT services provider FPT has been named a winner of the AI & Machine Learning Innovation Award at the 2026 InsurInnovator Connect (IIC) Asia Awards for iSuite, its AI-native digital insurance platform. The award honors organizations and solutions that drive innovation and shape the future of insurance across Asia, recognizing initiatives that deliver measurable impact and elevate industry standards.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330197417/en/

 

 

 

The accolade highlights iSuite’s role in transforming insurance operations through embedded intelligence. Built as an AI-powered platform, iSuite automates the full insurance lifecycle from customer onboarding to underwriting and claims, while unifying data across customers, agents, and partners. By embedding AI across core functions, it enables insurers to transition from manual, fragmented processes to a unified, data-driven operating model. In production, iSuite has reduced low-risk claims processing from days to minutes, increased straight-through processing rates to over 70%, and improved fraud detection speed by approximately 50%.

 

Organized in conjunction with the annual InsurInnovator Connect Asia conference, the IIC Asia Awards bring together industry leaders, innovators, and decision-makers across the insurance ecosystem. The program highlights forward-looking technologies and transformative business models redefining how insurers operate in an increasingly digital and customer-centric landscape, and is widely regarded as a benchmark of excellence in the regional insurance industry.

 

 

“The insurance industry is undergoing a fundamental shift from process-driven operations to intelligence-driven models,” said Truong Hoang Phuc, FPT Software Vice President and Director of Global Insurance and Finance, FPT Corporation. “Our AI-first approach embeds intelligence into core workflows such as underwriting and claims, transforming how decisions are made across the enterprise and beyond.”

 

 

With over two decades of experience in the insurance sector, FPT supports over 200 clients worldwide through a dedicated team of more than 3,000 specialists. The company’s workforce is backed by over 500 insurance-related certifications, reflecting deep domain expertise and a continued commitment to delivering high-quality, innovative solutions.

 

 

About FPT Corporation

 

 

FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam and operates in three core sectors: Technology, Telecommunications, and Education. Over more than three decades, FPT has consistently delivered impactful solutions to millions of individuals and tens of thousands of organizations worldwide. As an AI-first company, FPT is committed to elevating Vietnam’s position on the global tech map and delivering world-class AI-enabled solutions for global enterprises. FPT focuses on three critical transformations: Digital Transformation, Intelligence Transformation, and Green Transformation. In 2025, FPT reported a total revenue of USD 2.66 billion and a workforce of over 54,000 employees across its core businesses.

 

 

For more information about FPT’s global IT services, please visit https://fptsoftware.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330197417/en/